Lead Product(s) : Milnacipran HCl
Therapeutic Area : Musculoskeletal
Study Phase : Phase III
Sponsor : Forest Laboratories
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacy and Safety of Milnacipran in the Treatment of Fibromyalgia in an Elderly Population
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
August 17, 2011
Lead Product(s) : Milnacipran HCl
Therapeutic Area : Musculoskeletal
Highest Development Status : Phase III
Sponsor : Forest Laboratories
Deal Size : Inapplicable
Deal Type : Inapplicable